Clinical trial
Randomized Phase II Study of 2 Hypofractionated Radiotherapy Schedules for Low- and Intermediate-Risk Prostate Cancer
NCT01423474 is registered in ClinicalTrials.gov with CancerCare Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase II Study of 2 Hypofractionated Radiotherapy Schedules for Low- and Intermediate-Risk Prostate Cancer
- Lead sponsor
- CancerCare Manitoba
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- August 31, 2019
- Enrollment
- 152 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.